Arthritis and rheumatism (Arthritis Rheum)

Journal PubWeight™ 17252.64‹?›

Top papers

Rank Title Year PubWeight™‹?›
1 The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. 1988 111.05
2 The 1982 revised criteria for the classification of systemic lupus erythematosus. 1982 67.54
3 Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. 1997 43.47
4 Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. 1986 29.12
5 The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. 1990 27.50
6 Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. 1995 26.94
7 Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. 1980 21.86
8 Measurement of patient outcome in arthritis. 1980 21.31
9 Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. 1984 20.51
10 Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. 2008 19.80
11 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. 2010 18.82
12 American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. 1995 15.00
13 Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. 1992 14.73
14 The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. 1987 14.21
15 Nomenclature of systemic vasculitides. Proposal of an international consensus conference. 1994 14.16
16 Antibodies reacting with ribosomal ribonucleoprotein in connective tissue diseases. 1979 13.72
17 Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. 2008 13.08
18 Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. 1998 12.36
19 Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. 2000 11.84
20 The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. 1991 11.66
21 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. 2013 11.18
22 Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. 2003 10.65
23 Classification criteria for psoriatic arthritis: development of new criteria from a large international study. 2006 10.39
24 American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. 2008 9.94
25 Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria. 1996 9.88
26 A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. 2006 9.52
27 The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment. 2006 9.37
28 The prevalence of knee osteoarthritis in the elderly. The Framingham Osteoarthritis Study. 1987 9.24
29 Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three connecticut communities. 1977 9.14
30 The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. 1990 8.92
31 Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks. 2006 8.78
32 The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials. 1993 8.73
33 Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis. 1998 8.69
34 The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. 1990 8.67
35 The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. 2000 8.64
36 Preliminary criteria for the classification of the acute arthritis of primary gout. 1977 8.55
37 Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial. 2003 8.50
38 Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial. 2005 8.47
39 The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). 1990 8.36
40 The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. 1990 8.23
41 The prevalence and characteristics of fibromyalgia in the general population. 1995 7.97
42 Guidelines for the management of rheumatoid arthritis: 2002 Update. 2002 7.95
43 The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. 1991 7.94
44 Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. 2004 7.79
45 International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. 1999 7.67
46 The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. 1999 7.30
47 Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community. 1993 7.14
48 Progression of radiologic damage in patients with rheumatoid arthritis in clinical remission. 2004 7.13
49 Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra. 2004 7.07
50 Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. 2000 6.88
Next 50